22-16 Triple-Negative Breast Cancer is the most aggressive of all

11/27/22 • 25 min

Anixa is pioneering a new approach to preventing the truly aggressive triple-negative form of breast cancer. Based on research from Cleveland Clinic, this approach has the potential to treat other breast cancers as well as ovarian cancer. Dr. Amit Kumar is the President & CEO. More information is available at anixa.com.

Previous Episode

Dr. George Yancopoulos, CEO, Regeneron

Dr. George Yancopoulosis is the President and Chief Scientific Officer of Regeneron. Regeneron is successful on many levels but is perhaps best known for its Covid treatment, directly infusing antibodies. This, of course, requires innovative science ... but how do get students to become scientists? Dr. Yancopoulos has an answer.

Next Episode

22-46 Dr. Maria Maccecchini, Founder, President & CEO, Annovis Bio

Alzheimer’s, Parkinson’s and ALS, among others, are often grouped as Neurodegenerative Disorders. While they each present a different profile of symptoms, what do they have in common? Dr. Maria Maccecchini, the Founder, President & CEO of Annovis Bio, says, "Sticky proteins".